医疗费用报销市场（2026—2031）
医疗费用报销市场预计从2026年的11.13万亿美元增长至2031年的14.77万亿美元，预测期复合年增长率为5.82%。北美为当前最大市场，亚太地区增长最快。
市场研究正文
规模、增长、细分、驱动因素与关键问题
当前质量分 100.00，审核状态 accepted。结构化字段已按 RoboInd 内容层级组织。
核心结论
医疗费用报销市场预计从2026年的11.13万亿美元增长至2031年的14.77万亿美元，预测期复合年增长率为5.82%。北美为当前最大市场，亚太地区增长最快。
市场走势
结构化指标
| 指标 | 年份 | 数值 | 性质 |
|---|---|---|---|
| 复合年增长率 | 2031 | 5.82% | 机构预测 |
| 市场规模 | 2026 | USD 11.13 trillion | 机构预测 |
| 市场规模 | 2031 | USD 14.77 trillion | 机构预测 |
细分市场份额
市场结构
| 维度 | 细分项 | 年份 | 份额 |
|---|---|---|---|
| claim_type | underpaid claims | 2025 | 80.430% |
| geography | North America | 2025 | 42.540% |
| payer | public payers | 2025 | 46.760% |
| service_provider | physician offices and clinics | 2025 | 47.210% |
关键结论
- claim_type 维度中，underpaid claims 在 2025 年的公开份额为 80.43%。
- geography 维度中，North America 在 2025 年的公开份额为 42.54%。
- payer 维度中，public payers 在 2025 年的公开份额为 46.76%。
- service_provider 维度中，physician offices and clinics 在 2025 年的公开份额为 47.21%。
主要参与者
- UnitedHealth Group Incorporated
- CVS Health Corporation
- Elevance Health, Inc.
- The Cigna Group
- Health Care Service Corporation
增长驱动因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Expansion of Value-Based Care Models | +0.900% | Global, concentrated in North America and Europe | Medium term (2-4 years) |
| Rising Healthcare Service and Treatment Costs | +0.800% | Global, highest in Asia-Pacific, Latin America, and North America | Short term (≤ 2 years) |
| Chronic Disease and Aging-Related Utilization Growth | +0.700% | Global, most acute in Asia-Pacific and North America | Long term (≥ 4 years) |
| Public and Private Insurance Coverage Expansion | +0.500% | Asia-Pacific core, Middle East and Africa emerging, with spillover to South America | Medium term (2-4 years) |
| Digital Therapeutics and Medical AI Reimbursement Pathways | +0.500% | North America and Europe, with early gains in South Korea and Germany | Medium term (2-4 years) |
| Interoperable Real-World Evidence at Payment | +0.400% | Global, with North American and European regulatory frameworks leading | Long term (≥ 4 years) |
市场制约因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Complex Reimbursement Policies and Coding Requirements | -0.800% | Global, most acute in North America and Europe | Short term (≤ 2 years) |
| Fiscal Pressure on Public Payers and Reimbursement Rates | -0.700% | North America, Europe, and emerging markets with new public programs | Medium term (2-4 years) |
| Fragmented Clinical Data Ownership Across Provider Networks | -0.600% | Global, with particular severity in Asia-Pacific and South America | Long term (≥ 4 years) |
| Dual Fee-for-Service and Downside-Risk Contracts | -0.400% | North America, with early emergence in Europe | Medium term (2-4 years) |
报告关注的关键问题
What is driving growth in healthcare reimbursement?
Growth is supported by rising treatment costs, broader insurance coverage, chronic care demand, and the shift toward value-based payment models.
How large is healthcare reimbursement in 2026?
The healthcare reimbursement market is valued at USD 11.13 Trillion in 2026 and is projected to reach USD 14.77 Tillion by 2031.
Which claim category has the largest share?
Underpaid claims held 80.43% share in 2025, reflecting the need to identify and recover payments that do not match contracted terms.
Which payer category is growing fastest?
Private payers are forecast to grow at a 7.84% CAGR through 2031, supported by commercial and employer-sponsored coverage.
Which provider setting is growing fastest?
Diagnostic laboratories are forecast to grow at an 8.43% CAGR through 2031 as outpatient testing and monitoring needs expand.
Which region is expanding fastest?
Asia-Pacific is forecast to grow at a 6.43% CAGR through 2031 as insurance coverage and claims administration needs increase.
市场概览
- 增长最快市场：亚太地区
- 最大市场：北美
- 市场集中度：中等
查看来源：Mordor Intelligence